Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 171 Total
IMVT - Immunovant Inc - Stock Price Chart
TickerIMVT [NASD, RUT]
CompanyImmunovant Inc
CountryUSA
IndustryBiotechnology
Market Cap3.84BEPS (ttm)-1.89
P/E-EPS this Y-4.06%
Forward P/E-EPS next Y-19.49%
PEG-EPS past 5Y-
P/S-EPS next 5Y3.69%
P/B6.22EPS Q/Q-13.02%
Dividend-Sales Q/Q-
Insider Own58.06%Inst Own47.50%
Insider Trans-0.25%Inst Trans5.05%
Short Float15.24%EarningsMay 29/a
Analyst Recom1.00Target Price51.09
Avg Volume1.09M52W Range18.16 - 45.58
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salzmann PeterChief Executive OfficerMay 22 '24Sale29.6516,163479,2331,036,716May 24 04:15 PM
Barnett Eva ReneeChief Financial OfficerMay 22 '24Sale29.654,042119,845355,414May 24 04:18 PM
Macias William L.Chief Medical OfficerMay 22 '24Sale29.653,24796,274374,403May 24 04:13 PM
Butchko Julia G.Chief Development OfficerMay 22 '24Sale29.653,24796,274448,380May 24 04:14 PM
Levine Mark S.Chief Legal OfficerMay 22 '24Sale29.653,24296,125339,914May 24 04:10 PM
HOLO - MicroCloud Hologram Inc - Stock Price Chart
TickerHOLO [NASD]
CompanyMicroCloud Hologram Inc
CountryChina
IndustryElectronic Components
Market Cap8.20MEPS (ttm)-1.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-483.40%
P/S0.28EPS next 5Y-
P/B0.41EPS Q/Q-320.24%
Dividend-Sales Q/Q-
Insider Own69.53%Inst Own1.20%
Insider Trans0.00%Inst Trans-98.39%
Short Float68.46%Earnings-
Analyst Recom-Target Price-
Avg Volume10.71M52W Range1.50 - 113.00
MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.
PRTH - Priority Technology Holdings Inc - Stock Price Chart
TickerPRTH [NASD, RUT]
CompanyPriority Technology Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap354.71MEPS (ttm)-0.58
P/E-EPS this Y72.62%
Forward P/E23.63EPS next Y208.70%
PEG-EPS past 5Y-16.63%
P/S0.46EPS next 5Y-
P/B-EPS Q/Q31.66%
Dividend-Sales Q/Q11.18%
Insider Own83.45%Inst Own4.39%
Insider Trans-0.24%Inst Trans-4.85%
Short Float0.94%EarningsMay 09/b
Analyst Recom1.50Target Price7.62
Avg Volume48.70K52W Range2.62 - 5.05
Priority Technology Holdings, Inc. engages in the provision of merchant acquiring and commercial payments solutions with a platform of micro services that activate and monetize vertically specialized merchant networks. It operates through the following segments: SMB Acquiring Solutions, B2B Payables, and Enterprise Payments and BaaS. The SMB Acquiring Solutions segment offers full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO, direct sales, and vertically focused ISV channels. The B2B Payables segment refers to market AP automation solutions to corporations, software partners, and industry FIs. The Enterprise Payments and BaaS segment focuses on embedded finance and BaaS solutions to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The company was founded by John V. Priore on April 23, 2015 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kiewiet SeanChief Strategy OfficerMay 24 '24Sale4.519,85244,4331,241,853May 24 05:15 PM
Kiewiet SeanChief Strategy OfficerMay 23 '24Sale3.7640,000150,4001,251,705May 24 05:15 PM
Kiewiet SeanChief Strategy OfficerMay 22 '24Sale3.459,87534,0691,291,705May 24 05:15 PM
Kiewiet SeanChief Strategy OfficerMay 21 '24Sale3.521,0003,5201,301,580May 21 06:49 PM
Kiewiet SeanChief Strategy OfficerMay 20 '24Sale3.4821,10073,4281,302,580May 21 06:49 PM
AXDX - Accelerate Diagnostics Inc - Stock Price Chart
TickerAXDX [NASD]
CompanyAccelerate Diagnostics Inc
CountryUSA
IndustryMedical Devices
Market Cap29.11MEPS (ttm)-4.54
P/E-EPS this Y62.83%
Forward P/E-EPS next Y25.69%
PEG-EPS past 5Y21.16%
P/S2.39EPS next 5Y30.00%
P/B-EPS Q/Q56.66%
Dividend-Sales Q/Q3.88%
Insider Own45.18%Inst Own20.95%
Insider Trans-0.99%Inst Trans-
Short Float3.20%EarningsMay 08/a
Analyst Recom2.00Target Price1.00
Avg Volume79.44K52W Range0.73 - 11.90
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MASSARANY HANYDirectorMay 29 '24Option Exercise0.007,894032,154May 30 04:16 PM
FRANCESCONI LOUISEDirectorMay 29 '24Option Exercise0.007,894028,821May 30 04:25 PM
Regan JenniferDirectorMay 29 '24Option Exercise0.0012,631012,631May 30 04:25 PM
SCHULER JACK WDirectorMay 29 '24Option Exercise0.007,894015,488May 30 04:25 PM
Mertz Larry MichaelChief Technology OfficerMay 20 '24Option Exercise0.001,283082,114May 21 07:03 PM
INDP - Indaptus Therapeutics Inc - Stock Price Chart
TickerINDP [NASD]
CompanyIndaptus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap21.18MEPS (ttm)-1.78
P/E-EPS this Y-4.64%
Forward P/E-EPS next Y27.15%
PEG-EPS past 5Y56.03%
P/S-EPS next 5Y-
P/B2.26EPS Q/Q10.94%
Dividend-Sales Q/Q-
Insider Own30.86%Inst Own6.88%
Insider Trans0.00%Inst Trans12.55%
Short Float0.28%EarningsMay 08/b
Analyst Recom1.00Target Price10.00
Avg Volume88.42K52W Range1.56 - 4.08
Today 08:00AM Indaptus Therapeutics to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) -10.14%
May-29-24 08:00AM Indaptus Therapeutics to Present New Cohort Data Confirming Original Pulse-Prime Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting (GlobeNewswire) +12.20%
May-22-24 08:00AM Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company's Broad-Based, Pulse-Prime Immuno-Oncology Therapy for Advanced Solid Tumors (GlobeNewswire) +5.53%
May-08-24 12:54PM INDP Stock Earnings: Indaptus Therapeutics Misses EPS for Q1 2024 (InvestorPlace)
08:00AM Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-11-24 07:30AM Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting (GlobeNewswire) +9.13%
Mar-28-24 08:00AM Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference (GlobeNewswire) -10.04%
Mar-25-24 08:30AM Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting (GlobeNewswire) +6.90%
Mar-18-24 08:00AM Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 (GlobeNewswire)
Mar-13-24 07:30AM Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Glen R.10% OwnerAug 14 '23Buy2.3423,93456,0061,190,400Aug 16 06:01 PM
Anderson Glen R.10% OwnerAug 11 '23Buy2.1235,06474,3361,166,466Aug 16 06:01 PM
Anderson Glen R.10% OwnerAug 10 '23Buy1.9444,35486,0471,131,402Aug 16 06:01 PM
UMAC - Unusual Machines Inc - Stock Price Chart
TickerUMAC [AMEX]
CompanyUnusual Machines Inc
CountryUSA
IndustryShell Companies
Market Cap12.60MEPS (ttm)-0.32
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S20.32EPS next 5Y-
P/B0.59EPS Q/Q-169.67%
Dividend-Sales Q/Q-
Insider Own79.72%Inst Own0.18%
Insider Trans0.00%Inst Trans-
Short Float0.15%Earnings-
Analyst Recom-Target Price-
Avg Volume157.41K52W Range0.98 - 5.54
Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.
SMLR - Semler Scientific Inc - Stock Price Chart
TickerSMLR [NASD, RUT]
CompanySemler Scientific Inc
CountryUSA
IndustryMedical Devices
Market Cap205.31MEPS (ttm)2.78
P/E10.45EPS this Y-3.42%
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.99%
P/S3.12EPS next 5Y-
P/B2.58EPS Q/Q24.01%
Dividend-Sales Q/Q-12.65%
Insider Own22.35%Inst Own50.99%
Insider Trans0.00%Inst Trans38.76%
Short Float3.90%EarningsMay 07/a
Analyst Recom1.00Target Price40.00
Avg Volume127.71K52W Range20.88 - 53.38
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEMLER ERICDirectorSep 13 '23Buy28.1126,868755,25977,771Sep 13 07:05 PM
SEMLER ERICDirectorSep 12 '23Buy27.7025,903717,51350,903Sep 13 07:05 PM
SEMLER ERICDirectorSep 11 '23Buy26.9825,000674,50025,000Sep 13 07:05 PM
SGRP - Spar Group, Inc. - Stock Price Chart
TickerSGRP [NASD]
CompanySpar Group, Inc.
CountryUSA
IndustrySpecialty Business Services
Market Cap57.66MEPS (ttm)0.41
P/E5.84EPS this Y47.62%
Forward P/E19.75EPS next Y-61.29%
PEG-EPS past 5Y-
P/S0.22EPS next 5Y-
P/B1.73EPS Q/Q641.94%
Dividend-Sales Q/Q6.70%
Insider Own55.80%Inst Own9.40%
Insider Trans-8.19%Inst Trans34.11%
Short Float0.23%EarningsMay 15/b
Analyst Recom1.00Target Price7.00
Avg Volume363.46K52W Range0.70 - 2.75
SPAR Group, Inc. operates as a global merchandising and brand marketing services company, which engages in providing a broad range of sales enhancing services to retailers across most classes of trade, and consumer goods manufacturers and distributors around the world. It operates through the Americas, Asia-Pacific, and Europe, Middle East, and Africa (EMEA) geographical segments. The Americas segment includes the United States, Canada, Brazil, and Mexico. The Asia-Pacific segment refers to Japan, China, India, and Australia. The EMEA segment is involved in South Africa. The company was founded by Robert G. Brown and William H. Bartels in 1967 and is headquartered in Auburn Hills, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROWN ROBERT G/10% OwnerMay 28 '24Sale2.694,70012,6433,153,263May 28 04:47 PM
Matacunas Mike R.Chief Executive OfficerMay 15 '24Option Exercise0.0054,9590126,915May 17 02:40 PM
BARTELS WILLIAMS HDirectorMay 09 '24Sale1.801,000,0001,800,0004,709,837May 13 04:01 PM
SPAR Business Services IncAffiliated with Robert G BrownApr 01 '24Sale1.38150,000206,2521,065,538Apr 03 02:37 PM
BROWN ROBERT G/10% OwnerApr 01 '24Sale1.3550,00067,5003,257,963Apr 03 02:49 PM
IBIO - iBio Inc - Stock Price Chart
TickerIBIO [AMEX]
CompanyiBio Inc
CountryUSA
IndustryBiotechnology
Market Cap19.22MEPS (ttm)-16.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.72%
P/S384.45EPS next 5Y-
P/B0.76EPS Q/Q92.28%
Dividend-Sales Q/Q-
Insider Own0.16%Inst Own35.29%
Insider Trans0.00%Inst Trans1.54%
Short Float0.94%EarningsMay 13/a
Analyst Recom1.00Target Price5.00
Avg Volume3.93M52W Range1.02 - 17.60
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brenner MartinSee RemarksNov 01 '23Sale0.274,8811,296182,502Nov 03 04:01 PM
Brenner MartinSee RemarksOct 03 '23Sale0.305,2671,592187,383Oct 05 04:01 PM
Brenner MartinSee RemarksOct 02 '23Sale0.314,2151,311192,650Oct 03 04:01 PM
Brenner MartinSee RemarksAug 28 '23Sale0.315,0111,529196,865Aug 30 04:22 PM
Brenner MartinSee RemarksJul 27 '23Sale0.514,5152,308201,876Jul 28 04:01 PM
HRL - Hormel Foods Corp. - Stock Price Chart
TickerHRL [NYSE, S&P 500]
CompanyHormel Foods Corp.
CountryUSA
IndustryPackaged Foods
Market Cap16.86BEPS (ttm)1.39
P/E22.10EPS this Y-1.13%
Forward P/E18.25EPS next Y6.01%
PEG3.35EPS past 5Y-4.93%
P/S1.40EPS next 5Y6.60%
P/B2.15EPS Q/Q-14.08%
Dividend3.65%Sales Q/Q-3.03%
Insider Own47.09%Inst Own41.32%
Insider Trans-0.03%Inst Trans0.10%
Short Float3.28%EarningsMay 30/b
Analyst Recom3.54Target Price32.27
Avg Volume2.52M52W Range28.51 - 41.73
Hormel Foods Corp. engages in the manufacturing and marketing of branded food products. It operates through the following segments: Retail, Foodservice, and International. The Retail segment consists of the processing, marketing, and sale of food products sold predominantly in the retail market. The Foodservice segment includes the processing, marketing, and sale of food and nutritional products for foodservice, convenience store, and commercial customers. The International segment focuses on processing, marketing, and selling company products internationally. The company was founded by George A. Hormel in 1891 and is headquartered in Austin, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ourada Mark JGROUP VICE PRESIDENTApr 02 '24Option Exercise26.3813,800364,04441,850Apr 03 03:28 PM
Ourada Mark JGROUP VICE PRESIDENTApr 02 '24Sale35.5013,800489,90028,050Apr 03 03:28 PM
Murano Elsa ADirectorApr 02 '24Sale35.134,300151,06894,583Apr 03 03:29 PM
Coffey Mark AGROUP VICE PRESIDENTMar 28 '24Option Exercise26.3815,400406,25283,429Apr 01 10:58 AM
Myers Kevin LSENIOR VICE PRESIDENTMar 28 '24Option Exercise26.3810,000263,80048,708Apr 01 10:59 AM
1234567891018